Biovie BIVI
NASDAQ BIVI
$1.46 -0.01 (-0.68%)
At close: Oct 2, 2026 · 4:00 PM EDT

Biovie (BIVI) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Biovie (BIVI) reported Return on Capital Employed [ROCE] of -187.41% for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 100.70 percentage points from -86.70% a year earlier and down 74.96 percentage points from the prior quarter.

Analysis

Biovie (BIVI) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), Biovie posted Return on Capital Employed [ROCE] of -160.53%, down 74.95 percentage points from FY2025.

  • Return on Capital Employed [ROCE] has a five-year change of +4337.92 percentage points (FY2021 to FY2026).
  • By fiscal year, Return on Capital Employed [ROCE] came in at -85.58% in FY2025 (+69.10 pp), -154.68% in FY2024 (+189.05 pp), -343.73% in FY2023 (-37.91 pp) and -305.82% in FY2022 (+4192.63 pp).
  • The fiscal Q4 2026 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] since fiscal Q3 2024.
  • Year over year, Return on Capital Employed [ROCE] gained in six of the last eight quarters, with an average year-over-year change of +96.79 percentage points.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was fiscal Q4 2022 (a gain of 1485.68 percentage points); the low point was fiscal Q1 2022 (a drop of 1094.34 percentage points).
  • Per Business Quant data, the three fiscal quarters before Q4 2026 came in at -112.45% (Q3 2026), -84.03% (Q2 2026) and -85.28% (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Biovie 11.01 Mn 11.01 Mn - -187.41%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -187.41%
Mar 31, 2026 -112.45%
Dec 31, 2025 -84.03%
Sep 30, 2025 -85.28%
Jun 30, 2025 -86.70%
Mar 31, 2025 -84.81%
Dec 31, 2024 -108.76%
Sep 30, 2024 -155.18%
Jun 30, 2024 -168.14%
Mar 31, 2024 -271.12%
Dec 31, 2023 -513.76%
Sep 30, 2023 -290.51%
Jun 30, 2023 -175.76%
Mar 31, 2023 -143.77%
Dec 31, 2022 -129.90%
Sep 30, 2022 -175.61%
Jun 30, 2022 -143.57%
Mar 31, 2022 -605.19%
Dec 31, 2021 -650.57%
Sep 30, 2021 -1,123.04%
API Access

Biovie Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BIVI&period=max&api_key=YOUR_API_KEY